Quarterly report [Sections 13 or 15(d)]

Segment Information (Details)

v3.26.1
Segment Information (Details)
$ in Thousands
3 Months Ended
Mar. 31, 2026
USD ($)
segment
Mar. 31, 2025
USD ($)
Segment Reporting Information [Line Items]    
Number of segments | segment 1  
Total revenues $ 58,818 $ 53,333
Less:    
Cost of product sales 4,606 4,409
Provision for income taxes 3,003 65
Net income 8,654 11,446
Single reportable segment    
Segment Reporting Information [Line Items]    
Total revenues 58,818 53,333
Less:    
Employee related expenses 21,002 19,538
Commercial related expenses 7,040 5,339
Outside clinical trial related expenses 6,927 4,371
Cost of product sales 4,606 4,409
Consultants and third-party services 4,006 3,409
Other segment items 3,352 3,494
Interest expense, net 228 1,262
Provision for income taxes 3,003 65
Net income $ 8,654 $ 11,446